GO
Loading...

Finerman's Fine Print: Illumina Rejects Roche

Wednesday, 8 Feb 2012 | 5:29 PM ET

Karen Finerman, Metropolitan Capital Advisors, and Fast Money trader, provides insight on what's next for Illumina, on the heels its recent rejection of Roche's offer.